SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

SEMA3G functions as a novel prognostic biomarker associated with Wnt pathway in clear cell renal cell carcinoma

Article in Cellular Signalling (August 2023)

Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway

Article in PeerJ (April 2023)

Hypoxia-Regulated Gene Expression and Metastasis

Book chapter (April 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.